MFAP4 levels also correlate with the concentrations of many chemokines and chemokine receptors as well as immune checkpoints in glioma tissues, suggesting that it may influence the tumor microenvironment through multiple mechanisms composition. The gene discussed is MFAP4; the disease is central nervous system cancer.